Park West Asset Management LLC - STRONGBRIDGE BIOPHARMA PLC ownership

STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 64 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Park West Asset Management LLC ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q2 2019$239,000
-96.4%
76,446
-94.2%
0.01%
-96.5%
Q1 2019$6,587,000
-3.6%
1,322,659
-13.3%
0.29%
-14.5%
Q4 2018$6,835,000
-10.6%
1,525,608
-3.2%
0.34%
+21.6%
Q3 2018$7,642,000
+17.7%
1,575,608
+45.6%
0.28%
+14.9%
Q2 2018$6,491,000
-6.2%
1,081,800
+38.4%
0.24%
-21.4%
Q1 2018$6,919,000781,8000.31%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q2 2018
NameSharesValueWeighting ↓
CAXTON CORP 6,612,065$24,994,00026.38%
Ikarian Capital, LLC 3,271,238$12,365,0000.98%
NEA Management Company, LLC 4,141,308$15,654,0000.63%
KNOTT DAVID M 296,037$1,119,0000.61%
Alambic Investment Management, L.P. 61,364$232,0000.58%
Worth Venture Partners, LLC 185,153$700,0000.34%
683 Capital Management, LLC 458,971$1,735,0000.14%
BOOTHBAY FUND MANAGEMENT, LLC 382,400$1,445,0000.10%
Hudson Bay Capital Management LP 1,213,139$4,585,0000.08%
Walleye Capital LLC 52,961$200,0000.04%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders